SCI Pharmtech Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,344	1,524	1,204	899.74	864.22
Revenue Growth (YoY)	-11.81%	26.54%	33.83%	4.11%	-67.86%
Cost of Revenue	992.7	1,113	853.84	608.56	656.13
Gross Profit	351.03	410.67	350.32	291.18	208.09
Selling, General & Admin	157.96	169.7	140.93	132.56	104.08
Research & Development	37.82	42.68	49.09	39.65	30.35
Operating Expenses	195.78	212.38	190.02	172.21	134.43
Operating Income	155.25	198.29	160.3	118.97	73.66
Interest Expense	-4.94	-5.54	-6.29	-1.07	-0.04
Interest & Investment Income	4.63	9.98	6.17	6.49	10.04
Earnings From Equity Investments	-46.63	-23.73	-13.84	-12.56	-13.55
Currency Exchange Gain (Loss)	-	22.6	2.37	27.55	-15
Other Non Operating Income (Expenses)	-6.12	10.19	6.62	4.37	24.41
EBT Excluding Unusual Items	102.19	211.79	155.33	143.75	79.52
Gain (Loss) on Sale of Investments	-	3.62	-1.87	-14.07	2.24
Gain (Loss) on Sale of Assets	-	-	-0.58	-1.33	-
Other Unusual Items	-	-	0.37	101.2	-16.26
Pretax Income	102.19	646.86	364.19	387.82	65.51
Income Tax Expense	-5.18	112.18	69.47	79.04	9.81
Net Income	107.37	534.68	294.72	308.78	55.7
Net Income to Common	107.37	534.68	294.72	308.78	55.7
Net Income Growth	-79.92%	81.42%	-4.55%	454.40%	-84.53%
Shares Outstanding (Basic)	119	120	109	107	107
Shares Outstanding (Diluted)	119	120	110	108	108
Shares Change (YoY)	-0.54%	9.44%	1.87%	0.08%	-0.49%
EPS (Basic)	0.90	4.47	2.70	2.88	0.52
EPS (Diluted)	0.90	4.46	2.69	2.87	0.52
EPS Growth	-79.82%	65.80%	-6.27%	456.63%	-84.53%
Free Cash Flow	-389.68	-86.12	-813.59	-871.02	-490.75
Free Cash Flow Per Share	-3.27	-0.72	-7.42	-8.10	-4.57
Dividend Per Share	-	1.500	1.250	0.222	-
Dividend Growth	-	20.00%	462.56%	-	-
Gross Margin	26.12%	26.95%	29.09%	32.36%	24.08%
Operating Margin	11.55%	13.01%	13.31%	13.22%	8.52%
Profit Margin	7.99%	35.09%	24.47%	34.32%	6.44%
Free Cash Flow Margin	-29.00%	-5.65%	-67.56%	-96.81%	-56.79%
EBITDA	408.21	429.73	303.68	207.95	135.59
EBITDA Margin	30.38%	28.20%	25.22%	23.11%	15.69%
D&A For EBITDA	252.97	231.44	143.38	88.98	61.93
EBIT	155.25	198.29	160.3	118.97	73.66
EBIT Margin	11.55%	13.01%	13.31%	13.22%	8.52%
Effective Tax Rate	-	17.34%	19.07%	20.38%	14.98%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.